Google has confirmed that it is testing healthcare-related advertisements within AI Mode, the company’s AI-powered search experience, signaling the latest step in the integration of its advertising business into generative search results. The test, which is currently limited to healthcare advertisers in the United States and restricted to English-language queries, represents the first time Google has publicly acknowledged bringing ads from a heavily regulated vertical into its AI-driven interface. The confirmation from Google Ads Liaison Ginny Marvin follows weeks of industry speculation that healthcare ads had begun surfacing within AI-generated search experiences, and it provides the clearest signal yet of how the company intends to monetize its most ambitious reimagining of search.
The Scope of the Healthcare Ads Test in AI Mode
According to Marvin, the test is currently small in scale and applies exclusively to the healthcare vertical. Advertisers in the healthcare space who meet Google’s eligibility requirements can now have their ads appear within AI Mode responses, but only when users submit queries in English. The geographic restriction to the United States means that international healthcare advertisers will not yet have access to this placement, though the structure of the test suggests that Google is evaluating performance and compliance before considering broader rollout.
The confirmation came after weeks of mounting speculation. Industry observers and paid media professionals had noticed healthcare-related ads appearing within AI Mode and began questioning whether Google had quietly expanded its advertising program to include the category. The company’s willingness to confirm the test publicly, rather than dismiss it as a glitch or an anomaly, signals that this is a deliberate, planned expansion rather than an accidental exposure.
Which Campaign Types Are Eligible for AI Mode Healthcare Ads
Marvin outlined several campaign types that are eligible to participate in the test. Performance Max, Google’s fully automated campaign type, is included, as is AI Max with search term matching, a newer offering that combines AI-driven bidding and creative with explicit search term controls. Shopping campaigns and broad match campaigns are also eligible to serve ads within AI Mode for healthcare queries.
Importantly, the same campaign types are also eligible to serve ads in AI Overviews, Google’s earlier AI-powered search feature that provides summarized answers at the top of search results. This overlap suggests that Google is treating AI Mode and AI Overviews as part of a unified monetization strategy, with the same campaign infrastructure supporting both surfaces. For advertisers already running campaigns across these types, the transition into AI Mode may require minimal additional configuration, at least from a technical standpoint.
Why Healthcare Advertising Represents a Critical Test Case
Healthcare is one of Google’s most heavily regulated advertising categories. Advertisers in this vertical must comply with strict policies governing claims, disclaimers, patient data, and approved messaging, and Google subjects healthcare ads to elevated scrutiny before they are approved to run. The decision to begin testing healthcare ads in AI Mode therefore carries particular significance. If Google can successfully navigate the regulatory and trust-related challenges of this category, it will have established a template for bringing other regulated verticals into AI-generated search experiences.
Conversely, any missteps in healthcare advertising within AI Mode could slow the broader rollout of ads across the platform. The stakes are high. AI Mode is still in its early stages, and user trust in AI-generated content remains fragile. Placing ads, particularly for sensitive categories like healthcare, alongside AI-generated answers creates new risks around how users perceive the reliability and independence of the information they receive. Google’s approach to this test will be closely watched by regulators, advertisers, and competitors alike.
The same campaign types are also eligible to serve ads in AI Overviews, which suggests that Google is building toward a unified advertising model across its AI surfaces rather than treating each as a separate experiment.
Creative Restrictions in the Initial Phase
The test comes with meaningful creative limitations. According to Marvin, the first phase is restricted to ads that do not use pinned assets or text disclaimers. Pinned assets allow advertisers to lock specific headlines or descriptions into fixed positions within a responsive search ad, and text disclaimers are commonly used in healthcare advertising to satisfy regulatory requirements around risk information, side effects, or eligibility criteria.
By excluding these elements, Google is effectively limiting the pool of eligible healthcare creatives to those that do not rely on forced asset placement or mandatory disclaimer text. This constraint may reduce the number of healthcare advertisers who can participate in the initial test, particularly those in highly regulated subcategories such as prescription pharmaceuticals, where disclaimers are not optional. The restriction suggests that Google is prioritizing simplicity and control in the early phase, possibly to minimize the complexity of rendering ads within AI-generated responses where the layout and context cannot be guaranteed.
Implications for Marketers and Regulated Industries
For healthcare marketers, the test opens a potential new channel for visibility. AI Mode responses are highly prominent within the search experience, and ads placed within them could capture attention from users who are actively seeking health-related information. However, the creative restrictions and limited eligibility mean that the opportunity is currently narrow. Advertisers who rely heavily on pinned assets or disclaimers will need to wait for future phases of the test before they can participate.
For advertisers in other regulated industries, such as finance, legal services, and alcohol, the healthcare test serves as a bellwether. Google’s handling of the healthcare vertical will likely inform its approach to these categories. If the company determines that it can effectively manage compliance, user trust, and ad quality within AI Mode for healthcare, the path will be clearer for expanding into similarly regulated sectors. If challenges emerge, Google may proceed more cautiously or introduce additional safeguards before broadening access.
The test also raises questions about how Google intends to balance monetization with user experience. AI Mode is designed to provide comprehensive, conversational answers, and the introduction of ads into that environment creates inherent tension. Users may perceive ads as compromising the objectivity of AI-generated responses, particularly in healthcare contexts where accuracy and impartiality are critical. Google will need to demonstrate that ads are clearly distinguishable from organic AI content and that the presence of advertising does not influence the information provided by the model.
How the Test Came to Light
The test was first spotted by Senior Strategist Ben Goldman, who noticed healthcare ads appearing in AI Mode and raised the observation in response to Marvin’s Google Marketing Live 2026 takeaways on LinkedIn. Marvin’s public confirmation on the same platform provided the first official acknowledgment of the initiative. The exchange highlights the role that industry professionals continue to play in identifying and publicizing changes to Google’s advertising ecosystem, particularly in areas where the company has not issued formal announcements.
For advertisers and agencies, the discovery underscores the importance of monitoring live Google surfaces for changes that may not yet be documented in official help centers or product announcements. As AI Mode evolves, such observations will likely become an increasingly valuable source of competitive intelligence.
What to Watch as the Test Progresses
The test is currently small, but several developments are worth monitoring. First, whether Google expands eligibility to more healthcare advertisers, including those who rely on disclaimers and pinned assets, will indicate how quickly the company intends to scale. Second, the addition of new ad formats within AI Mode, such as image extensions, callout extensions, or sitelinks, would signal that Google is investing in richer ad experiences for the surface. Third, expansion into other regulated industries would confirm that the healthcare test is functioning as a pilot for a broader advertising program.
The timing of any expansion will also be meaningful. If Google moves quickly to broaden the test, it would suggest that early performance metrics are meeting expectations. If the company maintains a narrow scope for an extended period, it may indicate that compliance or user experience challenges are proving difficult to resolve. Either outcome will carry implications for how advertisers plan their AI Mode strategies going forward.
As AI Mode becomes a larger part of the Google search experience, the decisions made during this test period will shape not only how healthcare ads appear but also how the broader advertising industry adapts to a search landscape increasingly defined by generative AI. The healthcare test is small in scale, but its significance extends far beyond the vertical, offering the clearest view yet of Google’s vision for the future of search advertising.
